Acquisitions - Narrative (Details) - USD ($) $ in Thousands |
|
|
|
|
|
10 Months Ended |
12 Months Ended |
Aug. 11, 2021 |
Feb. 22, 2021 |
Jul. 02, 2020 |
May 13, 2020 |
Feb. 12, 2020 |
Dec. 31, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Compensation expense |
|
|
|
|
|
|
$ 46,780
|
$ 19,160
|
$ 3,532
|
| HDS-VH |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Controlling interest held by Company |
|
|
|
|
97.00%
|
|
|
|
|
| doc.ai Incorporated |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Consideration transferred |
|
$ 120,600
|
|
|
|
|
|
|
|
| Consideration, cash payable including via note payable |
|
29,000
|
|
|
|
|
|
|
|
| Cash payment to acquire business |
|
15,000
|
|
|
|
|
|
|
|
| Consideration payable, note payable |
|
14,000
|
|
|
|
|
|
|
|
| Contingent consideration |
|
10,300
|
|
|
|
|
|
|
|
| Equity-based consideration |
|
81,300
|
|
|
|
|
|
|
|
| Transaction related expenses |
|
800
|
|
|
|
|
|
|
|
| Compensation expense |
|
$ 8,800
|
|
|
|
|
|
|
|
| Revenue of acquiree since acquisition date |
|
|
|
|
|
$ 17,300
|
|
|
|
| Net loss of acquiree since acquisition date |
|
|
|
|
|
$ 3,900
|
|
|
|
| doc.ai Incorporated | Common stock |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Contingent consideration, instruments issuable, maximum |
|
1,145,790
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
|
9,039,117
|
|
|
|
|
|
|
|
| Equity interest issued at closing (in shares) |
|
(8,435,301)
|
|
|
|
|
|
|
|
| Equity interest issuable on first anniversary (in shares) |
|
603,816
|
|
|
|
|
|
|
|
| doc.ai Incorporated | Stock options |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Contingent consideration, instruments issuable, maximum |
|
485,922
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
|
2,444,361
|
|
|
|
|
|
|
|
| CareLinx Inc |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Consideration transferred |
$ 65,600
|
|
|
|
|
|
|
|
|
| Cash payment to acquire business |
55,200
|
|
|
|
|
|
|
|
|
| Equity-based consideration |
10,400
|
|
|
|
|
|
|
|
|
| Transaction related expenses |
$ 1,100
|
|
|
|
|
|
|
|
|
| Revenue of acquiree since acquisition date |
|
|
|
|
|
|
12,100
|
|
|
| Net loss of acquiree since acquisition date |
|
|
|
|
|
|
$ 4,200
|
|
|
| CareLinx Inc | Common stock |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
1,262,475
|
|
|
|
|
|
|
|
|
| CareLinx Inc | Stock options |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
295,758
|
|
|
|
|
|
|
|
|
| Visualize Health [Member] |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Cash payment to acquire business |
|
|
|
|
$ 2,000
|
|
|
|
|
| Contingent consideration |
|
|
|
|
1,900
|
|
|
|
|
| Equity-based consideration |
|
|
|
|
5,000
|
|
|
|
|
| Transaction related expenses |
|
|
|
|
200
|
|
|
|
|
| Goodwill, tax deductible |
|
|
|
|
700
|
|
|
|
|
| Goodwill, not tax deductible |
|
|
|
|
$ 4,500
|
|
|
|
|
| Mindsciences Inc [Member] |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Consideration transferred |
|
|
|
$ 7,600
|
|
|
|
|
|
| Equity-based consideration |
|
|
|
1,700
|
|
|
|
|
|
| Transaction related expenses |
|
|
|
$ 300
|
|
|
|
|
|
| Mindsciences Inc [Member] | Common stock |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
|
|
|
2,946,744
|
|
|
|
|
|
| Mindsciences Inc [Member] | Stock options |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
|
|
|
1,092,558
|
|
|
|
|
|
| Mindsciences Inc [Member] | Common Stock Retroactive [Member] |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
|
|
|
440,316
|
|
|
|
|
|
| Mindsciences Inc [Member] | Redeemable Convertible Preferred Stock Series C [Member] |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
|
|
|
6,179
|
|
|
|
|
|
| Mindsciences Inc [Member] | Common Stock And Equity Options [Member] |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Equity-based consideration |
|
|
|
$ 5,900
|
|
|
|
|
|
| Whitehat A I [Member] |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Consideration transferred |
|
|
$ 2,700
|
|
|
|
|
|
|
| Contingent consideration |
|
|
500
|
|
|
|
|
|
|
| Equity-based consideration |
|
|
2,200
|
|
|
|
|
|
|
| Transaction related expenses |
|
|
$ 300
|
|
|
|
|
|
|
| Whitehat A I [Member] | Common stock |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Contingent consideration, instruments issuable, maximum |
|
|
1,487,553
|
|
|
|
|
|
|
| Whitehat A I [Member] | Common stock |
|
|
|
|
|
|
|
|
|
| Business Acquisition [Line Items] |
|
|
|
|
|
|
|
|
|
| Equity interest issuable (in shares) |
|
|
1,425,200
|
|
|
|
|
|
|